Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Breast Cancer Research : BCR|March 15, 2011
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1Iain R Hutcheson, Lindy Goddard, Denise Barrow, et al.
Breast Cancer Research and Treatment|November 2, 2005
Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growthD J Britton, I R Hutcheson, J M Knowlden, et al.
Endocrine-Related Cancer|January 30, 2007
Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapyIain R Hutcheson, Janice M Knowlden, Helen E Jones, et al.
Breast Cancer Research : BCR|September 1, 2018
Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cellsIain R Hutcheson, Janice M Knowlden, Steve E Hiscox, et al.
Breast Cancer Research : BCR|August 10, 2007
Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cellsIain R Hutcheson, Janice M Knowlden, Steve E Hiscox, et al.
Breast Cancer Research : BCR|January 25, 2014
Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitroNicola J Jordan, Carol M Dutkowski, Denise Barrow, et al.
Endocrinology|February 15, 2003
Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cellsJanice M Knowlden, Iain R Hutcheson, Helen E Jones, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategiesR I Nicholson, I R Hutcheson, D Britton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combinationRobert I Nicholson, Iain R Hutcheson, Janice M Knowlden, et al.
Nature|November 14, 2008
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifenAntoni Hurtado, Kelly A Holmes, Timothy R Geistlinger, et al.
Pageof 5